A detailed history of Gts Securities LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Gts Securities LLC holds 16,000 shares of BSX stock, worth $1.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,000
Previous 17,900 10.61%
Holding current value
$1.45 Million
Previous $1.38 Million 2.76%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$72.96 - $84.0 $3.54 Million - $4.08 Million
48,538 Added 145.76%
81,838 $6.86 Million
Q2 2024

Aug 14, 2024

SELL
$67.33 - $77.71 $189,601 - $218,831
-2,816 Reduced 7.8%
33,300 $2.56 Million
Q1 2024

May 15, 2024

SELL
$57.6 - $68.62 $12,153 - $14,478
-211 Reduced 0.58%
36,116 $2.47 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $1.35 Million - $1.61 Million
27,848 Added 328.43%
36,327 $2.1 Million
Q3 2023

Nov 15, 2023

BUY
$50.19 - $54.68 $425,561 - $463,631
8,479 New
8,479 $447,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.